Prognostic factors for limited-stage small cell lung cancer: A study of 284 patients
Jun Chen, Ruoxiang Jiang, Yolanda I. Garces, Aminah Jatoi, Shawn M. Stoddard, Zhifu Sun, Randolph S. Marks, Yunpeng Liu, Ping Yang
20100101
2010 Feb 1
Lung Cancer
Prognostic factors for limited-stage small cell lung cancer: A study of 284 patients
Lung Cancer. 2010 Feb;67(2):221-226, Jun Chen, Ruoxiang Jiang, Yolanda I. Garces, Aminah Jatoi, Shawn M. Stoddard, Zhifu Sun, Randolph S. Marks, Yunpeng Liu, Ping Yang
Combined modality therapy is the standard care for limited stage-small cell lung cancer (LS-SCLC) and has led to a significant improvement in patients’ survival. This study sought to investigate and define the importance of prognostic effects of known and controversial factors especially the impact of smoking status and treatment strategies. A total of 284 patients with LS-SCLC were diagnosed and prospectively followed from 1997 to 2008 at Mayo Clinic; their characteristics and survival outcome were...
Editors' Choice
Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)
